Skip to Content
Series

Personalized drugs: How are they priced?

May 05, 2015 00:00 AM UTC
- Updated April 29, 2020 17:32 PM UTC

Fortune's Susie Gharib sits down with Novartis CEO Joseph Jimenez to talk about the company's advancements and what medicine personalization means for consumers.